PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 10, 2004New England Journal of Medicine6,400 citationsOpen Access

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

View Full Paper
SPSoonmyung PaikSSSteven ShakGTGong Tang

Key Points

Key points are not available for this paper at this time.

Abstract

The recurrence score has been validated as quantifying the likelihood of distant recurrence in tamoxifen-treated patients with node-negative, estrogen-receptor-positive breast cancer.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Paik et al. (2004) studied this question.

synapsesocial.com/papers/69dbd2bff7e0c66ced83666dhttps://doi.org/10.1056/nejmoa041588
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Flexible Methods for Analyzing Survival Data Using Splines, with Applications to Breast Cancer Prognosis1992 · 490 citations
  2. 2Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry2002 · 23 citations
  3. 3Expression of the 21 genes in the Recurrence Score assay and tamoxifen clinical benefit in the NSABP study B-14 of node negative, estrogen receptor positive breast cancer2005 · 109 citations
  4. 4Multi-gene Rt-pcr assay for predicting recurrence in node negative breast cancer patients-nsabp studies B-20 and B-142003 · 75 citations
  5. 5Observer variation in histological grading of breast cancer.1989 · 42 citations